Sign In
Buy VCYT
$48.69
+0.89 (+1.86%)
At Close: Jun 03, 2026
Veracyte, Inc. $VCYT Shares Sold by Assenagon Asset Management S.A.
03:30am, Thursday, 25'th Dec 2025
Assenagon Asset Management S.A. decreased its position in Veracyte, Inc. (NASDAQ: VCYT) by 96.7% in the undefined quarter, according to the company in its most recent filing with the Securities and Ex
Is This the Right Time to Add Veracyte Stock to Your Portfolio?
03:11pm, Tuesday, 23'rd Dec 2025
VCYT's Afirma and Decipher fuel strong test volume growth and a debt-free balance sheet, but rising macro costs and expenses temper the outlook.
Fisher Asset Management LLC Reduces Holdings in Veracyte, Inc. $VCYT
05:12am, Thursday, 04'th Dec 2025
Fisher Asset Management LLC lowered its position in Veracyte, Inc. (NASDAQ: VCYT) by 11.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and
Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term
10:52am, Tuesday, 02'nd Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Head to Head Review: Veracyte (NASDAQ:VCYT) vs. Nanovibronix (NASDAQ:NAOV)
02:14am, Tuesday, 02'nd Dec 2025
Nanovibronix (NASDAQ: NAOV - Get Free Report) and Veracyte (NASDAQ: VCYT - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the
Advantage Alpha Capital Partners LP Sells 7,161 Shares of Veracyte, Inc. $VCYT
03:44am, Friday, 28'th Nov 2025
Advantage Alpha Capital Partners LP lessened its position in shares of Veracyte, Inc. (NASDAQ: VCYT) by 27.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 19
AXQ Capital LP Buys New Shares in Veracyte, Inc. $VCYT
03:36am, Tuesday, 25'th Nov 2025
AXQ Capital LP bought a new position in shares of Veracyte, Inc. (NASDAQ: VCYT) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up
08:31am, Tuesday, 11'th Nov 2025
Veracyte surges 27.5% after Q3 earnings and revenues beat estimates, driven by strong Decipher and Afirma test growth.
Veracyte to Participate in Upcoming Investor Conferences
08:30am, Thursday, 06'th Nov 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, announced today it will participate in the following investor conferences. Wolfe Resea
Veracyte, Inc. (VCYT) Q3 2025 Earnings Call Transcript
11:46pm, Tuesday, 04'th Nov 2025
Veracyte, Inc. ( VCYT ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Shayla Gorman - Director of Investor Relations Marc Stapley - CEO & Director Rebecca Chambers - Executiv
Veracyte (VCYT) Q3 Earnings and Revenues Beat Estimates
07:26pm, Tuesday, 04'th Nov 2025
Veracyte (VCYT) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.19 per share a year ago.
Veracyte Announces Third Quarter 2025 Financial Results
04:05pm, Tuesday, 04'th Nov 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the third quarter ended September 30, 2025. “
Y Intercept Hong Kong Ltd Has $1.10 Million Stake in Veracyte, Inc. $VCYT
04:40am, Tuesday, 04'th Nov 2025
Y Intercept Hong Kong Ltd trimmed its position in shares of Veracyte, Inc. (NASDAQ: VCYT) by 11.5% during the second quarter, according to the company in its most recent disclosure with the Securities
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
04:15pm, Monday, 03'rd Nov 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VYCT #AfirmaGRID--Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced the publication of two studies demonstrating t
State of New Jersey Common Pension Fund D Buys 19,590 Shares of Veracyte, Inc. $VCYT
03:27am, Sunday, 02'nd Nov 2025
State of New Jersey Common Pension Fund D raised its stake in Veracyte, Inc. (NASDAQ: VCYT) by 39.9% during the undefined quarter, according to the company in its most recent 13F filing with the Secur
